Search Results 301-310 of 16334 for melatonin receptor agonists

  1. Chronic pain: Medication decisions - Mayo Clinic

    Pain medications at a glance · Blocks opioid receptors, which stop the release of chemicals that cause pain · Can stop the transmission of pain signals.

  2. Sleep Medicine Fellowship (Minnesota) - Residencies and Fellowships - Mayo Clinic College of Medicine & Science

    Mayo Clinic School of Graduate Medical Education offers a one-year Sleep Medicine Fellowship in Rochester, Minnesota.

  3. Telmisartan and amlodipine (oral route) - Side effects & dosage - Mayo Clinic

    Telmisartan is an angiotensin II receptor blocker (ARB). It works by blocking a substance in the body that causes blood vessels to tighten. As a result, the ...

  4. Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  5. Preparing for nuclear medicine therapy - Mayo Clinic

    A member of the nuclear medicine therapy team talks with a woman before she begins intravenous peptide receptor radionuclide therapy (PRRT). This type of ...

  6. Delayed sleep phase - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  7. Nortriptyline (oral route) - Side effects & dosage - Mayo Clinic

    This medicine is available only with your doctor's prescription. This product is available in the following dosage forms: Capsule; Solution. Back to top ...

  8. Mithri Junna, M.D. - Mayo Clinic Faculty Profiles

    The clinical and research interests of Mayo Clinic's Mithri Junna, M.D., span the fields of sleep medicine, epilepsy, neurophysiology and neurology.

  9. A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Anti-N-Methyl-D-Aspartic Acid Receptor (NMDAR) Or Anti-Leucine-Rich Glioma-Inactivated 1 (LGI1) Encephalitis (Cielo) - Mayo Clinic

    A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Anti-N-Methyl-D-Aspartic Acid Receptor (NMDAR) ...

  10. A Study of Pembrolizumab (MK-3475) Versus Placebo in Combination with Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer - Mayo Clinic

    ... Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer. Print details. Share; Facebook · Twitter. Overview ...